This column is from Trendlines, a business newsletter that covers the forces shaping the economy in Boston and beyond. If you’d like to receive it via email on Mondays, Wednesdays, and Fridays, sign up here.
It’s Boston’s biggest divorce since Gisele and Tom split, but this one is epically acrimonious and has real-life repercussions for the region’s hospital industry and its patients.
The news: Dana-Farber Cancer Institute said on Thursday that it would end its long and nationally acclaimed adult oncology partnership with Brigham and Women’s Hospital. Instead, it plans to open a new freestanding cancer hospital with Beth Israel Deaconess Medical Center where the Joslin Diabetes Center now stands in the Longwood Medical Area. (Joslin will relocate.)
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect